Targeting the weight within: obesity pharmacotherapy in cardiovascular disease US$ 21.65 Min. order: 1 piece ★★★★★ 4.3 (200 reviews) Sold : Login>>
CagrisSema is a once-weekly injection of semaglutide and cagrilintide. Phase 2 clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a promising US$ 24.23 Min. order: 1 piece ★★★★★ 4.2 (109 reviews) Sold : Login>>
VisualAbstract: Combined cagrilintide and semaglutide for weight management well-tolerated in early clinical trials US$ 24.31 Min. order: 1 piece ★★★★★ 4.9 (221 reviews) Sold : Login>>
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines US$ 20.88 Min. order: 1 piece ★★★★★ 4.3 (44 reviews) Sold : Login>>
Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial? US$ 22.18 Min. order: 1 piece ★★★★★ 4.4 (90 reviews) Sold : Login>>